- Home
- ACTU vs CIK Comparison
ACTU vs CIK Comparison
Compare ACTU & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- CIK
- Stock Information
- Founded
- ACTU 2015
- CIK 1987
- Country
- ACTU United States
- CIK United States
- Employees
- ACTU N/A
- CIK N/A
- Industry
- ACTU
- CIK Finance/Investors Services
- Sector
- ACTU
- CIK Finance
- Exchange
- ACTU NYSE
- CIK Nasdaq
- Market Cap
- ACTU 135.0M
- CIK 156.6M
- IPO Year
- ACTU 2024
- CIK N/A
- Fundamental
- Price
- ACTU $10.35
- CIK $2.83
- Analyst Decision
- ACTU Strong Buy
- CIK
- Analyst Count
- ACTU 1
- CIK 0
- Target Price
- ACTU $20.00
- CIK N/A
- AVG Volume (30 Days)
- ACTU 71.1K
- CIK 115.4K
- Earning Date
- ACTU 05-21-2025
- CIK 01-01-0001
- Dividend Yield
- ACTU N/A
- CIK 9.03%
- EPS Growth
- ACTU N/A
- CIK N/A
- EPS
- ACTU N/A
- CIK N/A
- Revenue
- ACTU N/A
- CIK N/A
- Revenue This Year
- ACTU N/A
- CIK N/A
- Revenue Next Year
- ACTU N/A
- CIK N/A
- P/E Ratio
- ACTU N/A
- CIK N/A
- Revenue Growth
- ACTU N/A
- CIK N/A
- 52 Week Low
- ACTU $5.51
- CIK $2.50
- 52 Week High
- ACTU $11.73
- CIK $3.19
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- CIK 53.58
- Support Level
- ACTU N/A
- CIK $2.81
- Resistance Level
- ACTU N/A
- CIK $2.83
- Average True Range (ATR)
- ACTU 0.00
- CIK 0.03
- MACD
- ACTU 0.00
- CIK 0.01
- Stochastic Oscillator
- ACTU 0.00
- CIK 83.33
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations, and individuals.